Navigation Links
New ImmunoSet(TM) ELISA Development Kits
Date:9/2/2008

ANN ARBOR, Mich., Sept. 2 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life sciences and translational research markets, has launched a new portfolio of thoroughly characterized ELISA development kits called ImmunoSet(TM). This cost effective portfolio of products to assay proteins in various matrices contains the basic components and protocol for the development of five 96 well colorimetric enzyme immunoassays. Assay Designs has an aggressive plan for the development and release of the ImmunoSet products beginning with kits for the detection of mouse and rat heme oxygenase-1 (HO-1) and p53/MDM2 complexes.

"With this initial launch of unique antibody sets for our new ImmunoSet product line, Assay Designs is enabling customers with cost effective tools to improve the output of their research," stated Dan Calvo, President and CEO. "We will continue to monitor the scientific literature, market trends, and our own antibody sales to expand this important product line as customer demand dictates."

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress.


'/>"/>
SOURCE Assay Designs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
2. AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test
3. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
4. Oncothyreon announces prioritization plan for development programs
5. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
6. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
7. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
8. RainDance Technologies Appoints Olex Vice President, System Development
9. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
10. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
11. BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief ... ), Inc. has been selected for membership in ARCS Alumni Hall of ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):